NASDAQ: RVMDRevolution Medicines Inc Stock Ownership - Who owns Revolution Medicines?
Insider buying vs selling
Have Revolution Medicines Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-25 | 60,000 | $4.09 | $245.40kBuy |
| Jack Anders | Chief Financial Officer | 2025-11-25 | 5,418 | $17.00 | $92.11kBuy |
| Jack Anders | Chief Financial Officer | 2025-11-25 | 5,418 | $74.00 | $400.93kSell |
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-25 | 3,000 | $75.00 | $225.00kSell |
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-25 | 3,000 | $75.00 | $225.00kSell |
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-25 | 60,000 | $75.08 | $4.50MSell |
| Jeff Cislini | General Counsel | 2025-11-18 | 13,388 | $70.14 | $939.01kSell |
| Jeff Cislini | General Counsel | 2025-11-18 | 13,388 | $42.45 | $568.32kBuy |
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-18 | 20,000 | $4.09 | $81.80kBuy |
| Mark A. Goldsmith | President and Chief Executive Officer | 2025-11-18 | 20,000 | $70.38 | $1.41MSell |
RVMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RVMD insiders and whales buy or sell their stock.
RVMD Shareholders
What type of owners hold Revolution Medicines Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.10% | 15,663,094 | $1.24B | Institution |
| Farallon Capital Management LLC | 7.57% | 14,625,692 | $1.15B | Institution |
| Janus Henderson Group PLC | 5.87% | 11,356,054 | $896.22M | Institution |
| Wellington Management Group LLP | 5.08% | 9,813,436 | $774.48M | Institution |
| Baker Bros Advisors LP | 4.89% | 9,455,357 | $746.22M | Institution |
| Fmr LLC | 4.86% | 9,401,687 | $741.98M | Institution |
| Blackrock Inc | 4.31% | 8,327,758 | $657.23M | Institution |
| Thilo Schroeder | 4.18% | 8,085,752 | $638.13M | Insider |
| Nextech Invest Ltd | 3.93% | 7,601,087 | $599.88M | Institution |
| Paradigm Biocapital Advisors LP | 3.22% | 6,223,291 | $491.14M | Institution |
RVMD vs Biotech Stocks
Revolution Medicines Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.